{"id":46160,"date":"2025-11-08T15:19:08","date_gmt":"2025-11-08T07:19:08","guid":{"rendered":"https:\/\/flcube.com\/?p=46160"},"modified":"2025-11-08T15:19:09","modified_gmt":"2025-11-08T07:19:09","slug":"zhaoke-ophthalmology-indonesia-distribution-deal-brimochol-pf-eyes-on-market-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46160","title":{"rendered":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China\u2011listed <strong>Zhaoke Ophthalmology Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/6622:HKG\">HKG: 6622<\/a>)<\/strong> announced a new distribution and supply agreement with Indonesia\u2019s <strong>PT Ferron Par Pharmaceuticals<\/strong> for its core eye\u2011drop, <strong>BRIMOCHOL\u202fPF<\/strong>. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-agreement-highlights\">Agreement Highlights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Exclusive Distribution<\/strong> \u2013 PT\u202fFerron Par receives sole rights to import, promote, distribute, market and sell BRIMOCHOL\u202fPF in Indonesia.<\/li>\n\n\n\n<li><strong>Financial Structure<\/strong> \u2013 Zhaoke will receive an upfront transfer fee plus future milestone payments tied to predefined performance criteria (e.g., sales thresholds, registration milestones).<\/li>\n\n\n\n<li><strong>Strategic Alignment<\/strong> \u2013 The partnership leverages Ferron\u2019s established Indonesian supply chain and Zhaoke\u2019s clinical expertise in presbyopia treatment.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-brimochol-pf-product-snapshot\">BRIMOCHOL\u202fPF \u2013 Product Snapshot<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Indication<\/strong><\/td><td>Once\u2011daily eye drop for presbyopia (age\u2011related near\u2011vision blur).<\/td><\/tr><tr><td><strong>Fixed\u2011Dose Combination<\/strong><\/td><td>Miotic\u202fcarbachol + \u03b1\u2082\u2011agonist brimonidine.<\/td><\/tr><tr><td><strong>Development Rights<\/strong><\/td><td>Zhaoke secured commercialization rights in Greater China, South Korea and select Southeast Asian markets in May\u202f2022 from Visus Therapeutics, Inc.<\/td><\/tr><tr><td><strong>Regulatory Progress<\/strong><\/td><td>FDA NDA accepted (June\u202f2025) with <strong>PDUFA<\/strong> date <strong>Jan\u202f28\u202f2026<\/strong>; the product entered the U.S. market via a 2024 merger with <strong>Tenpoint Therapeutics Ltd.<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Rapid Penetration<\/strong> \u2013 PT\u202fFerron\u2019s nationwide distribution network provides a ready platform for introducing an innovative, once\u2011daily presbyopia treatment to the growing Indonesian ophthalmic market, estimated to generate strong incremental revenue for Zhaoke.<\/li>\n\n\n\n<li><strong>Milestone Growth<\/strong> \u2013 The structured payment schedule aligns Zhaoke\u2019s upside with both regulatory milestones and commercial performance, potentially enhancing its valuation profile.<\/li>\n\n\n\n<li><strong>Strategic Portfolio Expansion<\/strong> \u2013 The deal complements Zhaoke\u2019s existing Greater China and South\u2011Korea presence, positioning the firm as a regional leader in vision\u2011care therapeutics.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements concerning the partnership, financial expectations, and regulatory milestones. Actual results may differ materially from those expressed herein due to market competition, regulatory changes, and other risks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46161,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[942,44,4384,166],"class_list":["post-46160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-hkg-6622","tag-ophthalmology","tag-pt-ferron-par-pharmaceuticals","tag-zhaoke-ophthalmology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46160\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion\" \/>\n<meta property=\"og:description\" content=\"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46160\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-08T07:19:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-08T07:19:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion\",\"datePublished\":\"2025-11-08T07:19:08+00:00\",\"dateModified\":\"2025-11-08T07:19:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0809.webp\",\"keywords\":[\"HKG: 6622\",\"Ophthalmology\",\"PT Ferron Par Pharmaceuticals\",\"Zhaoke Ophthalmology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46160#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46160\",\"name\":\"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0809.webp\",\"datePublished\":\"2025-11-08T07:19:08+00:00\",\"dateModified\":\"2025-11-08T07:19:09+00:00\",\"description\":\"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46160\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0809.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0809.webp\",\"width\":1080,\"height\":608,\"caption\":\"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46160#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46160","og_locale":"en_US","og_type":"article","og_title":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion","og_description":"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.","og_url":"https:\/\/flcube.com\/?p=46160","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-08T07:19:08+00:00","article_modified_time":"2025-11-08T07:19:09+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46160#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46160"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion","datePublished":"2025-11-08T07:19:08+00:00","dateModified":"2025-11-08T07:19:09+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46160"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46160#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","keywords":["HKG: 6622","Ophthalmology","PT Ferron Par Pharmaceuticals","Zhaoke Ophthalmology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46160#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46160","url":"https:\/\/flcube.com\/?p=46160","name":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46160#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46160#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","datePublished":"2025-11-08T07:19:08+00:00","dateModified":"2025-11-08T07:19:09+00:00","description":"China\u2011listed Zhaoke Ophthalmology Ltd. (HKG: 6622) announced a new distribution and supply agreement with Indonesia\u2019s PT Ferron Par Pharmaceuticals for its core eye\u2011drop, BRIMOCHOL\u202fPF. The deal grants PT\u202fFerron exclusive import, promotion and retail rights for the product across Indonesia, with Zhaoke to receive an upfront fee and milestone\u2011based payments contingent on market performance.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46160#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46160"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46160#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","width":1080,"height":608,"caption":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46160#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Zhaoke Ophthalmology Indonesia Distribution Deal \u2013 BRIMOCHOL PF Eyes on Market Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0809.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46160"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46160\/revisions"}],"predecessor-version":[{"id":46162,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46160\/revisions\/46162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46161"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}